CROSS COUNTRY HEALTHCARE INC
CCRNNasdaqIndustrials · Services-Help Supply Services · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $293.4M | $379.2M | $2.02B | $2.80B | $1.68B | $836.4M |
| Operating income | −$84.4M | −$16.9M | $112.7M | $269.9M | $139.3M | −$9.2M |
| Net income | −$490,000 | $2.7M | $72.6M | $186.0M | $132.0M | −$13.0M |
| Total assets | $449.0M | $589.3M | $681.1M | $949.6M | $732.8M | $357.0M |
| Total liabilities | $126.1M | $170.3M | $213.4M | $498.1M | $435.3M | $202.1M |
| Equity | $322.8M | $419.0M | $467.7M | $451.5M | $294.3M | $154.4M |
| EPS (diluted) | $-0.02 | $0.08 | $2.05 | $4.95 | $3.53 | $-0.36 |
| Shares out. | 32.8M | 34.7M | 36.8M | 38.1M | 37.5M | 36.9M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −28.8%
- Net margin
- −0.2%
- Return on equity
- −0.2%
- Return on assets
- −0.1%
- Return on capital (ROCE)
- −22.7%
- Liabilities / assets
- 28.1%
- Debt / equity
- 0.39×
- Book value / share
- $9.84
- Revenue growth (YoY)
- −22.6%
- Net income growth (YoY)
- −118.2%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- 5.47safe
- Accruals / assets
- −10.9%clean
- Piotroski F-Score
- 6/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 3 warning● 4 good- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Positive operating cash flow
- Clean earnings (low accruals)
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Boston PartnersPassive (13G)May 14, 2026
- Dimensional Fund Advisors LpPassive (13G)Apr 9, 2026
- Vanguard Group IncPassive (13G)Mar 26, 2026
- Alliancebernstein L.P.Passive (13G)Feb 17, 2026
- Magnetar Financial LlcActivist (13D)Dec 10, 2025
- Goldman Sachs Group IncPassive (13G)Nov 12, 2025
- Blackrock, Inc.Passive (13G)Jul 16, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 824,524 | 1.0 | -22.8% |
| Apr 30, 2026 | 1.1M | 3.2 | -6.2% |
| Apr 15, 2026 | 1.1M | 3.7 | -10.4% |
| Mar 31, 2026 | 1.3M | 2.8 | -5.3% |
| Mar 13, 2026 | 1.3M | 1.8 | +2.6% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Results of operations · Regulation FD disclosureMay 7, 2026
- Entered a material agreement · Regulation FD disclosure · Other material eventMay 7, 2026
- Regulation FD disclosureApr 17, 2026
- Director / officer changeMar 30, 2026
- Director / officer changeMar 17, 2026
- Director / officer changeMar 10, 2026
- Results of operations · Regulation FD disclosureMar 4, 2026
- Regulation FD disclosureFeb 23, 2026
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SCHEDULE 13GMay 14, 2026
- 10-QMay 8, 2026
- DEFA14AFORM DEFA14AMay 7, 2026
- DEFA14AFORM DEFA14AMay 7, 2026
- DEFA14AFORM DEFA14AMay 7, 2026
- 8-KMay 7, 2026
- DEFA14AFORM DEFA14AMay 7, 2026
- 8-KFORM 8-KMay 7, 2026
- 8-KApr 17, 2026
- SCHEDULE 13G/AApr 9, 2026
- 4STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIESApr 2, 2026
- 4STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIESApr 2, 2026
- 4STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIESApr 2, 2026
- 4STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIESApr 2, 2026
- 4STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIESApr 2, 2026
Event-driven situations (2)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.